China’s foray into the automotive industry makes perfect sense for any serious, powerful economy. Every major economic power has its own car brands. China has them now, in droves.
The U.S. goods deficit with China fell by roughly $2 billion in September, coming in at $15.03 billion. China has dropped to fourth place in terms of the countries in which the U.S. has its biggest goods gap.
China is beating the U.S. to the Moon, namely the dark side of the Moon we never see from Earth. It’s colder there. And darker. And China has the energy technologies they’ve invented themselves to make machines work there. We do not.
Democrats on the House Committee on Small Business kept to their year-long messaging that tariffs are raising costs and hurting companies. There were many interesting themes from the Nov. 20 hearing titled How Main Street is Revitalizing Domestic Manufacturing.
The Senate Special Committee on Aging was back at it this week discussing the woeful predicament of the domestic generic drug industry and its import-facing supply chain. This time, the Committee heard from four generic drug makers opposed to advocacy groups and Washington think tanks.
The August trade deficit fell a significant 23.8%, with exports flat and imports down 5% due in large part to the 90-day reprieve from the so-called “Liberation Day” tariffs expiring.
AbilityOne, a government program from 1938, sought out to provide employment for the disabled. Why are most defense contractors increasingly skeptical of it?
The Netherlands is the latest example of a country succumbing to China’s leadership position in critical supply chains.
If Argentina imports aren’t lowering supermarket beef prices, perhaps an investigation into the cartelization of the big, globalist meat packers will finally have an impact?
Witnesses at a Senate hearing on Wednesday, Oct. 29 titled “The Future of Biotech” discussed ways to facilitate reshoring and making it attractive to expand in the U.S. and conduct R&D here instead of in China.
